1. Home
  2. IDYA vs TROX Comparison

IDYA vs TROX Comparison

Compare IDYA & TROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • TROX
  • Stock Information
  • Founded
  • IDYA 2015
  • TROX 2018
  • Country
  • IDYA United States
  • TROX United States
  • Employees
  • IDYA N/A
  • TROX N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • TROX Major Chemicals
  • Sector
  • IDYA Health Care
  • TROX Industrials
  • Exchange
  • IDYA Nasdaq
  • TROX Nasdaq
  • Market Cap
  • IDYA 2.0B
  • TROX 1.6B
  • IPO Year
  • IDYA 2019
  • TROX 2005
  • Fundamental
  • Price
  • IDYA $17.05
  • TROX $7.24
  • Analyst Decision
  • IDYA Strong Buy
  • TROX Buy
  • Analyst Count
  • IDYA 13
  • TROX 7
  • Target Price
  • IDYA $53.58
  • TROX $13.50
  • AVG Volume (30 Days)
  • IDYA 887.8K
  • TROX 1.9M
  • Earning Date
  • IDYA 05-06-2025
  • TROX 04-30-2025
  • Dividend Yield
  • IDYA N/A
  • TROX 6.90%
  • EPS Growth
  • IDYA N/A
  • TROX N/A
  • EPS
  • IDYA N/A
  • TROX N/A
  • Revenue
  • IDYA $7,000,000.00
  • TROX $3,074,000,000.00
  • Revenue This Year
  • IDYA $89.14
  • TROX $5.47
  • Revenue Next Year
  • IDYA $291.34
  • TROX $5.15
  • P/E Ratio
  • IDYA N/A
  • TROX N/A
  • Revenue Growth
  • IDYA N/A
  • TROX 7.86
  • 52 Week Low
  • IDYA $16.88
  • TROX $6.64
  • 52 Week High
  • IDYA $44.42
  • TROX $20.70
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 31.80
  • TROX 42.00
  • Support Level
  • IDYA $17.05
  • TROX $6.90
  • Resistance Level
  • IDYA $18.90
  • TROX $7.44
  • Average True Range (ATR)
  • IDYA 0.91
  • TROX 0.32
  • MACD
  • IDYA 0.01
  • TROX 0.10
  • Stochastic Oscillator
  • IDYA 6.27
  • TROX 63.04

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. North America, Asia-Pacific and Europe the Middle East, and Africa regions contribute the vast majority of revenue.

Share on Social Networks: